Tonsillectomy, with or without adenoidectomy, conducted in both children and adults is
worldwide one of the most commonly performed surgical procedures in otorhinolaryngology,
and the number of tonsillectomies has increased over the recent decades. In Denmark,
approximately 8.000 tonsillectomies are performed annually. The main indications for
surgery are recurrent episodes of acute tonsillitis or upper airway obstruction due to
adenotonsillar hypertrophy.
Although commonly performed, tonsillectomy is associated with significant morbidity of
which postoperative pain and post tonsillectomy haemorrhage (PTH) are the most frequent.
PTH is a major and potentially life-threatening complication of tonsil surgery.
Postoperative pain lasts for approximately two weeks, and may in severe cases result in
delayed discharge, a visit at the emergency department or readmission for pain control,
re-hydration, and treatment of possible underlaying infection. The incidences of PTH vary
between 0.3 and more than 10%. This variation may be caused by different definitions of
PTH, but also differences in populations and indications. Cold steel tonsillectomy is
considered to be the gold standard surgical technique, but several hot techniques
including bipolar techniques, diathermy, and coblation have been developed and used for
tonsillectomy. Until now these hot instruments have not proven better than the gold
standard technique in reducing PTH, and it is recommended, that these hot techniques
should be used with caution. Recently, a new Impedance-dependent tissue sealer device
(BiZactTM) has been manufactured and approved for tonsil operations (19). Preliminary
results are promising in terms of a PTH rate of 4.5%, a shortened operative time in the
hands of both experienced and training surgeons with a median time of 5.1 minutes (range
1.5-26.5 minutes), and a reduced intraoperative blood loss between 1-10 milliliters.
Ideally, when a gold standard technique is replaced by a new technique, it is recommended
that the decision should be based on evidence provided by RCTs involving several centers.
The aim of the present is to conduct a RCT to investigate whether tonsillectomy performed
with a new hot technique (BiZactTM) is beneficial or at least non-inferior to the gold
standard cold steel technique in terms of incidence of post-tonsillectomy morbidity,
interoperative factors, patient satisfaction, and health related quality of life.
The study design is a double blind, multi-centre randomised controlled trial (RCT).
Patients, assessors, and investigators will be blinded to randomisation outcome.
Patients will be recruited at five Dept. Otorhinolaryngology: Region Hospital West,
Holstebro, DK, Southwest Regional Hospital, Esbjerg, DK, Lillebaelt Regional Hospital,
Vejle, DK, Southern Regional Hospital, Soenderborg, DK, and Aalborg University Hospital,
Aalborg, DK.
A total of 1250 eligible patients referred to tonsillectomy on benign indication, who
fulfil inclusion criteria and have signed declaration of consent, will be enrolled and
randomised in the study; 625 patients are randomized to surgery performed by steel
devices (Cold steel group), and 625 patients to surgery by an electrosurgical device
(BiZactTM) (Hot group)
In the "cold steel group" the peritonsillar space is dissected with metal instruments,
and bleeding is typically controlled by ligation or electrocautery. In the "hot group"
the peritonsillar space is dissected and sealed in one step by a bipolar instrument
(BiZactTM). The instrument uses Valley Lab adjustable bipolar energy. Energy is
automatically adjusted and delivered to the tissue in order minimize thermal tissue
damage and seal blood vessels less than 3mm in diameter while dividing the soft tissue.
An Inter-Rim analysis will be conducted after 650 included patients have fulfilled the
study protocol.
In order to strengthen study homogeneity, a pilot-study will initially be carried out
with the first ten patients at each of the involved otorhinolaryngology departments.
Randomization is computer generated. Random sequences of 5000 numbers with equal numbers
of group assignments will be obtained and concealed at the Tonsil database website
(www.tonsil.dk).
Randomisation will be performed automatically by ticking a box on a page of the Tonsil
database website.
At the preoperative consultation or at the emergency department, a doctor not involved in
the study, will establish registration of the patient in the database and carry out the
randomisation.
After the randomisation procedure has been carried out, the outcome will be registered on
a hidden page of the Tonsil database website, and it will not be possible to change the
outcome. The randomization outcome will only be visible on the web-page from the day of
surgery to the day after surgery. Hereafter, it will not be possible to see the
randomisation outcome. The operating surgeon will not be able to influence the
randomisation outcome.
The investigators hypothesise, that tonsillectomy performed with a bipolar
electrosurgical device (BiZactTM) is noninferior to tonsillectomy performed with cold
steel technique in terms of affecting postoperative morbidity defined as PTH demanding
reoperation with haemostasis and pain.
The present study will elucidate whether tonsillectomy performed with a bipolar
electrosurgical instrument BiZactTM induces alleged beneficial effects or at least is
noninferior to tonsillectomy performed with cold steel instruments. Moreover, should the
study uncover that tonsillectomy performed with a bipolar electrosurgical instrument
BiZactTM can reduce postoperative morbidity, frequency of reoperations, as well as
surgical time, it may potentially optimise future treatment for patients and reduce
socio-economic costs. Thus, the present RCT will be followed with an alongside economic
evaluation.